Healthcare | June 24, 2025
Biocon Biologics collaborates with National Cancer Society Malaysia
The program will start with providing bTrastuzumab to cancer patients facing treatment delays due to budget constraints
The program will start with providing bTrastuzumab to cancer patients facing treatment delays due to budget constraints
Breztri is an inhaled triple-combination therapy approved for the treatment of chronic obstructive pulmonary disease
Women Health Card was launched exclusively for women health workers of the Tiruchirappalli City Corporation
FlexiTubes will showcase range of eco-friendly and innovative tube options
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
Infections with H. pylori affect over 43 percent of the world’s population with a wide range of gastrointestinal disorders
Reinforces position as first commercially approved contract development and manufacturing organization (CDMO) for ADCs in North America
Potential to optimize and build on the synergies in commercial operations, distribution, manufacturing, supply chain etc.
The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements
We now rank 3rd in pharmaceutical production by volume and 14th by value
Subscribe To Our Newsletter & Stay Updated
